Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aksel Siva

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
European Journal of Neurology|November 8, 2021
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trialPatrick Vermersch, Celia Oreja-Guevara, Aksel Siva, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2026
Neuro-behcet's syndrome: epidemiology, mechanisms, and emerging strategies in diagnosis and treatmentEmine Rabia Koc, Sanja Gluscevic, Abdulkadir Tunc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Cerebellar volume loss in radiologically isolated syndromeIlena C George, Mohamed Mounir El Mendili, Matilde Inglese, et al.
Annals of Neurology|July 28, 2017
Myelopathy in Behçet's disease: The Bagel SignUgur Uygunoglu, Burcu Zeydan, Yesim Ozguler, et al.
Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.
Plos One|June 20, 2023
Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markersElif Everest, Ugur Uygunoglu, Melih Tutuncu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic studyBilgin Öztürk, Esra Taşkıran, Serkan Demir, et al.
The Journal of Headache and Pain|November 29, 2014
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache FederationDimos D Mitsikostas, Lars Edvinsson, Rigmor H Jensen, et al.
Agri : Agri (Algoloji) Dernegi'Nin Yayin Organidir = the Journal of the Turkish Society of Algology|October 27, 2022
The frequency and related factors of primary headaches in patients with Hashimoto thyroiditisRabia Gökçen Gözübatik Çelik, Derya Uludüz Ulu, Esra Hatipoğlu, et al.
CNS Drugs|September 16, 2024
Early Disease-Modifying Treatments for Presymptomatic Multiple SclerosisBurcu Zeydan, Christina J Azevedo, Naila Makhani, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
European Journal of Neurology|November 8, 2021
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trialPatrick Vermersch, Celia Oreja-Guevara, Aksel Siva, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 17, 2026
Neuro-behcet's syndrome: epidemiology, mechanisms, and emerging strategies in diagnosis and treatmentEmine Rabia Koc, Sanja Gluscevic, Abdulkadir Tunc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Cerebellar volume loss in radiologically isolated syndromeIlena C George, Mohamed Mounir El Mendili, Matilde Inglese, et al.
Annals of Neurology|July 28, 2017
Myelopathy in Behçet's disease: The Bagel SignUgur Uygunoglu, Burcu Zeydan, Yesim Ozguler, et al.
Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.
Plos One|June 20, 2023
Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markersElif Everest, Ugur Uygunoglu, Melih Tutuncu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic studyBilgin Öztürk, Esra Taşkıran, Serkan Demir, et al.
The Journal of Headache and Pain|November 29, 2014
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache FederationDimos D Mitsikostas, Lars Edvinsson, Rigmor H Jensen, et al.
Agri : Agri (Algoloji) Dernegi'Nin Yayin Organidir = the Journal of the Turkish Society of Algology|October 27, 2022
The frequency and related factors of primary headaches in patients with Hashimoto thyroiditisRabia Gökçen Gözübatik Çelik, Derya Uludüz Ulu, Esra Hatipoğlu, et al.
CNS Drugs|September 16, 2024
Early Disease-Modifying Treatments for Presymptomatic Multiple SclerosisBurcu Zeydan, Christina J Azevedo, Naila Makhani, et al.
Pageof 18